Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Pieris Pharmaceuticals Inc | Equity | 720795103 | 98120 | 32383 | SH | DFND | 1 | 0 | 32383 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Pieris Pharmaceuticals | |||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 297 | 98041 | SH | DFND | 1 | 98041 | 0 | 0 | May 18th, 2022 01:14AM | May 18th, 2022 01:14AM | Pieris Pharmaceuticals | |||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001172661-22-001498 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | MIRABELLA FINANCIAL SERVICES LLP | 1538853 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 39 | 12800 | SH | SOLE | 12800 | 0 | 0 | May 18th, 2022 01:11AM | May 18th, 2022 01:11AM | Pieris Pharmaceuticals | ||||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001907254-22-000002 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WEALTH EFFECTS LLC | 1907254 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 244 | 80400 | SH | SOLE | 0 | 0 | 80400 | May 17th, 2022 01:59AM | May 17th, 2022 01:59AM | Pieris Pharmaceuticals | ||||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001892688-22-000045 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Lynx1 Capital Management LP | 1910456 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 3443 | 1136319 | SH | OTR | 1 | 0 | 1136319 | 0 | May 17th, 2022 01:59AM | May 17th, 2022 01:59AM | Pieris Pharmaceuticals | |||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001802630-22-000005 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Soleus Capital Management, L.P. | 1802630 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 12529 | 4134868 | SH | SOLE | 4134868 | 0 | 0 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | Pieris Pharmaceuticals | ||||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001606587-22-001178 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Samalin Investment Counsel, LLC | 1544366 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 1515 | 500 | SH | SOLE | None | 0 | 0 | 500 | May 17th, 2022 01:57AM | May 17th, 2022 01:57AM | Pieris Pharmaceuticals | |||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001591986-22-000016 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Aquilo Capital Management, LLC | 1591986 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 11238 | 3708882 | SH | SOLE | 3708882 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Pieris Pharmaceuticals | ||||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR/A | 0001581655-22-000003 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Alpine Global Management, LLC | 1581655 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 33 | 10800 | SH | SOLE | 10800 | 0 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Pieris Pharmaceuticals | ||||
nasdaq:pirs | nasdaq:pirs Shareholders | 13F-HR | 0001567619-22-010951 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Cubist Systematic Strategies, LLC | 1603465 | PIERIS PHARMACEUTICALS INC | COM | 720795103 | 593 | 195830 | SH | DFND | 1 | 0 | 195830 | 0 | May 17th, 2022 01:56AM | May 17th, 2022 01:56AM | Pieris Pharmaceuticals |